Share Price, page-84

DEV shaping up to be what could be the best nearology play -
congratulations to those that saw the opportunity early
back slaps all round....
Some of the others are struggling = PUR sub 0.03c as an example...and it has the cross LOL.
10th Nov 21 was the date assays were announced in the lab - 6 weeks = 22nd dec
AGM 23rd and stated 4 to 6 weeks from then.
So looking good for the week before Christmas around the 22nd Dec 21 for results IMO.
Could get DHEM results soon and expect Nangus Rd drill start announcement.





November Winners: ASX investors were spooked by Omicron, but wooed by Julimar, hydrogen and the metaverse

Top 3 ASX winners in November

For the second month in a row the ASX was hit by a major sell-off in the last few days of the month and it took the bourse from what was then a 0.5% gain to a 1.56% loss in November.

Just when we thought we were out of the worst of COVID, with some states and nations reopening borders and our COVID vaccine tally growing another ~3.6 million to reach 87% of over-16s fully vaxxed, the Omicron variant emerged and sent markets and borders into retreat again.

But coming in first was another stock with exposure to virtual reality in Indoor Skydive (ASX:IDZ), which gained 229%.

During the month it appointed a new director in defence industry executive Mark Smethurst and opened its fourth FREAK entertainment centre in the Macquarie shopping centre in Sydney. It offers VR games, including escape rooms.

Taking the silver medal was Environmental Clean Technologies (ASX:ECT), gaining 212% on the ASX in November.

The company has a number of clean energy technologies under development in lignite, hydrogen and waste conversion. But it is the company’s hydrogen refinery in Victoria that has excited investors the most.

In bronze was DevEx Resources (ASXEV), gaining 126%. The biggest news out of the company was diamond drilling results at its nickel-copper Sovereign project.

Arguably the bigger catalyst for growth was Chalice Mining’s (ASX:CHN) maiden resource at Julimar, being a discovery DevEx and dozens of explorers are trying to replicate.

But one thing DevEx boasts that no other nearology plays can is having Chalice chairman Tim Goyder on its board.

There is one other Julimar nearology play in November’s ASX winners list in Caspin Resources (ASX:CPN) and its point of difference to other plays is having Chalice itself as a shareholder.

Reference
stockh _ _d.

Google www.Devex resources.etc etc
click News
6^th article down.